Search Results - Corey Langer

Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database by Patrick Bou‐Samra, Austin Chang, Feredun Azari, Gregory Kennedy, Alix Segil, Emily Guo, Melina Marmarelis, Corey Langer, Sunil Singhal

Get full text

607 TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in... by Li Zhang, Goetz Kloecker, Christian Rolfo, Wallace Akerley, Miklos Pless, Lubos Petruzelka, Zoran Andric, Joachim Aerts, Libor Havel, Jeffrey Ward, Richard Greil, David E Gerber, Janusz Milanowski, Angelo Delmonte, Sujith Kalmadi, Rodryg Ramlau, Rupesh Kotecha, Corey Langer, Ticiana A Leal, Manuel Cobo Dols, Jaromír Roubec, Thierry Berghmans, Rajiv Panikkar, Michael Eaton, Mussawar Iqbal

Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLC by Omar Elghawy, MD, Adam Barsouk, MD, Jonathan H. Sussman, BS, Benjamin A. Bleiberg, MD, Lauren Reed-Guy, MD, Christopher D’Avella, MD, Aditi Singh, MD, Christine Ciunci, MD, MSCE, Kyle Robinson, MD, John Kosteva, MD, Corey Langer, MD, Roger B. Cohen, MD, Charu Aggarwal, MD, MPH, Melina Marmarelis, MD, MSCE, Lova Sun, MD, MSCE

Get full text